Trial
NCT07221513
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Salubris Biotherapeutics Inc
Collaborators
—
Condition
HFrEF - Heart Failure With Reduced Ejection Fraction
Intervention
JK07
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-15